We also observed that T-DXd-induced HLA-DR expression in DCs was inhibited by anti-IFN-I antibodies, indicating that the cGAS-STING pathway in cancer cells indirectly drives DC activation through IFN-I. This evidence concerns the gene STING1 and cancer.